AI-generated summary
The authors ran a randomized, double-blind trial of 22 patients with recurrent herpes labialis, comparing acyclovir cream with photobiomodulation against acyclovir with sham laser. They report lower pain intensity in the photobiomodulation group at two and three days, smaller lesions at seven and ten days, and higher patient satisfaction. The sample was small, so the findings should be read cautiously.
- Participants
- 22
- Who or what was studied
- Patients with symptomatic recurrent herpes labialis
- Wavelengths
- 940 nm
- Limits stated in the abstract
- The trial enrolled only 22 patients, so the results are based on a small sample.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 4 J/cm2
- Power
- 100 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Wavelength, Laser, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.